Background Image
Previous Page  149 / 156 Next Page
Information
Show Menu
Previous Page 149 / 156 Next Page
Page Background

147

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

293

Shaiova L, Mori M, Anderson K, Loewen G, Ghalie R, Homel P, Portenoy R. Administration

of morphine sulfate extended-release capsules via gastrostomy: dissolution study and

case reports. J Palliat Med 2007; 10(5): 1063-1067.

294

Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to

evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain

Symptom Manage 2009; 37(1): 85-93.

295

Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ, Yoon JW, Kim KH, Kwon JY. Maintenance

anaesthetics during remifentanil-based anaesthesia might affect postoperative pain

control after breast cancer surgery. Br J Anaesth 2010; 105(5): 661-667.

296

Shirakami G, Teratani Y, Fukuda K. Nocturnal episodic hypoxemia after ambulatory breast

cancer surgery: comparison of sevoflurane and propofol-fentanyl anesthesia. J Anesth

2006; 20(2): 78-85.

297

Shirakami G, Teratani Y, Segawa H, Matsuura S, Shichino T, Fukuda K. Omission of fentanyl

during sevoflurane anesthesia decreases the incidences of postoperative nausea and vo-

miting and accelerates postanesthesia recovery in major breast cancer surgery. J Anesth

2006; 20(3): 188-195.

298

Sidiropoulou T, Buonomo O, Fabbi E, Silvi MB, Kostopanagiotou G, Sabato AF, Dauri M. A

prospective comparison of continuous wound infiltration with ropivacaine versus single-

injection paravertebral block after modified radical mastectomy. Anesth Analg 2008;

106(3): 997-1001.

299

Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G,

Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P.

Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain

in Italian patients: results of an open-label, multicentre, observational study. Clin Drug

Investig 2008; 28(7): 399-407.

300

Singhal AK, Mishra S, Bhatnagar S, Singh R. Epidural morphine analgesia compared with

intravenous morphine for oral cancer surgery with pectoralis major myocutaneous flap

reconstruction. Acta Anaesthesiol Scand 2006; 50(2): 234-238.

301

SITTIG H.-B. Verbesserung der Lebensqualität in der Palliativtherapie durch Bisphospho-

nate bei Knochenmetastasen. Refresher Palliativmedizin. Stuttgart Thieme 2010; 1 (1):

R1 – R12.

302

Skiveren J, Haedersdal M, Philipsen PA, Wiegell SR, Wulf HC. Morphine gel 0.3% does not

relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-

controlled study. Acta Derm Venereol 2006; 86(5): 409-411.

303

Slatkin NE, Rhiner MI, Gould EM, Ma T, Ahdieh H. Long-term tolerability and effectiveness

of oxymorphone extended release in patients with cancer. J Opioid Manag 2010; 6(3):

181-191.

304

Slatkin NE, Xie F, Messina J, Segal TJ. Fentanyl buccal tablet for relief of breakthrough pain

in opioid-tolerant patients with cancer-related chronic pain. J Support Oncol 2007; 5(7):

327-334.

Literaturverzeichnis